18F-FDG PET/CT of Cervical Carcinoma

被引:31
|
作者
Patel, Chirag N. [1 ]
Nazir, Sarfraz A. [2 ]
Khan, Zubair [2 ]
Gleeson, Fergus V. [2 ]
Bradley, Kevin M. [2 ]
机构
[1] St James Univ Hosp, Dept Nucl Med, Leeds LS9 7TF, W Yorkshire, England
[2] Churchill Hosp, Dept Radiol, Oxford OX3 7LJ, England
关键词
cervical carcinoma; FIGO; PET/CT; response assessment; POSITRON-EMISSION-TOMOGRAPHY; LYMPH-NODE METASTASES; CANCER; FLUORODEOXYGLUCOSE; BIOMARKER;
D O I
10.2214/AJR.10.5084
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
OBJECTIVE. This article outlines the role of FDG PET/CT in patients with cervical carcinoma for evaluating tumor extent, assessing treatment response, and detecting disease recurrence. CONCLUSION. There is increasing evidence that FDG PET/CT has a role in the primary evaluation of cervical carcinoma-in particular, for evaluating lymph node status and distant metastatic disease. PET/CT is also helpful to determine prognosis, assess treatment response, and evaluate disease recurrence.
引用
收藏
页码:1225 / 1233
页数:9
相关论文
共 50 条
  • [1] The Performance of 18F-FDG PET and 18F-FDG PET/CT in Detection of Carcinoma of Unknown Primary
    Dong, M.
    Zhao, K.
    Zhao, J.
    Guan, Y.
    Liu, Z.
    Ruan, L.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S275 - S275
  • [2] Cervical and Thoracic Actinomycosis on 18F-FDG PET/CT
    Singla, Suhas
    Singh, Harmandeep
    Mukherjee, Anirban
    Karunanithi, Sellam
    Bal, Chandrasekhar
    Kumar, Rakesh
    [J]. CLINICAL NUCLEAR MEDICINE, 2014, 39 (07) : 623 - 624
  • [3] Efficacy of 18F-FDG PET/CT in the evaluation of patients with recurrent cervical carcinoma
    Mittra, Erik
    El-Maghraby, Tarek
    Rodriguez, Cesar A.
    Quon, Andrew
    McDougall, I. Ross
    Gambhir, Sanjiv S.
    Iagaru, Andrei
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 (12) : 1952 - 1959
  • [4] Evaluation of 18F-FDG PET/CT in Early-Stage Cervical Carcinoma
    Yu, Lijuan
    Jia, Chengye
    Wang, Xin
    Lu, Peiou
    Tian, Mohan
    Wang, Wenzhi
    Lou, Ge
    [J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2011, 341 (02): : 96 - 100
  • [5] Efficacy of 18F-FDG PET/CT in the evaluation of patients with recurrent cervical carcinoma
    Erik Mittra
    Tarek El-Maghraby
    Cesar A. Rodriguez
    Andrew Quon
    I. Ross McDougall
    Sanjiv S. Gambhir
    Andrei Iagaru
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2009, 36 : 1952 - 1959
  • [6] 18F-FDG PET/CT of Transitional Cell Carcinoma
    Patil, Vivek V.
    Wang, Zhen J.
    Sollitto, Richard A.
    Chuang, Kai-Wen
    Konety, Badrinath R.
    Hawkins, Randy A.
    Coakley, Fergus V.
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 2009, 193 (06) : W497 - W504
  • [7] 18F-FDG PET/CT in Metastatic Pilomatrix Carcinoma
    Vadrucci, Manuela
    Gilardi, Laura
    Crivelli, Filippo
    Baroli, Alberto
    Lomuscio, Giuseppe
    [J]. CLINICAL NUCLEAR MEDICINE, 2016, 41 (12) : E525 - E526
  • [8] 18F-FDG PET/CT IN DIFFERENTIATED THYROID CARCINOMA
    Larg, M. I.
    Barbus, E.
    Gabora, K.
    Pestean, C.
    Cheptea, M.
    Piciu, D.
    [J]. ACTA ENDOCRINOLOGICA-BUCHAREST, 2019, 15 (02) : 203 - 208
  • [9] 18F-FDG PET/CT in the evaluation of ovarian carcinoma
    Rusu, G.
    Olariu, E.
    Alexiev, A.
    Hitu, L.
    Spinu, E.
    Gabora, K.
    Achimas-Cadariu, P.
    Piciu, D.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S475 - S476
  • [10] 18F-FDG PET/CT in Oral Cuniculatum Carcinoma
    Dejust, Sebastien
    El Farsaoui, Khadija
    Bellefqih, Sara
    Lalire, Paul
    Morland, David
    [J]. CLINICAL NUCLEAR MEDICINE, 2019, 44 (09) : 741 - 742